Identification of small molecule lead compounds for visceral leishmaniasis using a novel ex vivo splenic explant model system.
BACKGROUND: New drugs are needed to treat visceral leishmaniasis (VL) because the current therapies are toxic, expensive, and parasite resistance may weaken drug efficacy. We established a novel ex vivo splenic explant culture system from hamsters infected with luciferase-transfected Leishmania dono...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2011-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!